Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

The State Street SPDR S&P Biotech ETF (XBI) was launched on January 31, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. For a long ...

A smart beta exchange traded fund, the State Street SPDR S&P Pharmaceuticals ETF (XPH) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart ...

Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole. Like all ...

Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.

The current generation of deals, which is likely to involve AbbVie (NYSE: ABBV), Merck & Co Inc (NYSE: MRK), Bristol-Myers Squibb Co (NYSE: BMY), and Gilead Sciences Inc (NYSE: GILD), is focused on ...

We recently published 10 Most Popular Analyst Calls to Watch This Week. VanEck Pharmaceutical ETF (NASDAQ:PPH) is one of the trending stocks. Many analysts are picking healthcare stocks as indicators ...

Here is our list of the 7 cheap pharmaceutical stocks to buy according to hedge funds. Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending The seventh stock on our ...